Abstract
The limited availability of organs for transplant has vastly popularized implantation of left ventricular assist devices. Right ventricular failure is a continued problem with an incidence as high as 44 %, significantly decreasing survival after left ventricular assist devices (LVAD) implantation. Survival is significantly better when LVAD patients at high risk for right ventricular failure (RVF) are converted directly to biventricular assist device (BiVAD) therapy instead of LVAD with subsequent right ventricular assist device (RVAD) implantation. The options available for biventricular assistance entail a total artificial heart (TAH) or additional right-sided placement of a continuous flow/pulsatile device which could be para-corporeal or implantable. The HeartWare HVAD (HeartWare International, Framingham, MA) device in a biventricular configuration is a very attractive option. This report details experiences and techniques for implantation of the HVAD in such a configuration.
Original language | English (US) |
---|---|
Pages (from-to) | 197-200 |
Number of pages | 4 |
Journal | Indian Journal of Thoracic and Cardiovascular Surgery |
Volume | 32 |
Issue number | 3 |
DOIs | |
State | Published - Sep 1 2016 |
Keywords
- Biventricular failure
- Left ventricular assist device
- Right ventricular failure
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
- Pulmonary and Respiratory Medicine
- Surgery